BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31622599)

  • 1. Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma.
    Wenzina J; Holzner S; Puujalka E; Cheng PF; Forsthuber A; Neumüller K; Schossleitner K; Lichtenberger BM; Levesque MP; Petzelbauer P
    J Invest Dermatol; 2020 Apr; 140(4):878-890.e5. PubMed ID: 31622599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Phenotypic Plasticity of Cutaneous Melanoma: A Complex Puzzle.
    Joshi SS; Hornyak TJ
    J Invest Dermatol; 2020 Apr; 140(4):743-745. PubMed ID: 32200877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
    Widmer DS; Hoek KS; Cheng PF; Eichhoff OM; Biedermann T; Raaijmakers MIG; Hemmi S; Dummer R; Levesque MP
    J Invest Dermatol; 2013 Oct; 133(10):2436-2443. PubMed ID: 23474946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
    Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
    J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
    Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
    Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
    Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
    Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
    Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
    BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
    Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
    Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
    Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
    Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
    Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
    Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging molecular targets in melanoma invasion and metastasis.
    Orgaz JL; Sanz-Moreno V
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):39-57. PubMed ID: 23095214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
    van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
    J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.